Home
Clinical Resources Search
PQI: Cabozantinib (Cabometyx®)

Cabozantinib (Cabometyx®)

Download PQI pdf 0.25MB

Last Updated: August 30, 2024

By: Collin Dempsey PharmD, BCPS

About this PQI

The purpose of this PQI is to provide a concise and comprehensive resource for proper medication management of patients utilizing Cabozantinib. Utilizing this resource should assist to decrease medication toxicities, improve medication adherence, and improve overall patient outcomes.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Hepatocellular Carcinoma (HCC) Renal Cell Carcinoma (RCC) Thyroid Cancer Cabometyx Cabozantinib

PQI

Frequently Searched

Supported by

Cabozantinib (Cabometyx®)

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol

PQI: Encorafenib (Braftovi®) and Binimetinib (Mektovi®) for the Management of NSCLC

PQI: Bone Health and the Cancer Patient

PQI: Encorafenib (Braftovi®) + Cetuximab (Erbitux®) + mFOLFOX6 for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

PQI in Action: Proactive Symptom Management in Myelofibrosis

PQI in Action: Sonidegib (Odomzo®) Patient Management

PQI in Action: Larotrectinib (Vitrakvi®) Overview

S8 Bonus Eps 2: Inside ASCO 2025

S8 E15: Supporting Survivors at Work

S8 E14: Advancing Geriatric Oncology

S8 Ep 13: Supporting Patients Through Financial Assistance

Readiness Tracker

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Sorafenib (Nexavar®) for the Treatment of Hepatocellular Carcinoma and Transition to Second-line Regorafenib (Stivarga®)

PQI: Regorafenib (Stivarga®) in the Treatment of Hepatocellular Carcinoma

PQI: Durvalumab (Imfinzi®) Therapy Overview

Treatment Support Kit: Cabozantinib

PQI: Tivozanib (Fotivda®) for Relapsed or Refractory Advanced Renal Cell Carcinoma

S7 Ep 2: Insights on Navigating Kidney Cancer Care

Treatment Support Kit: Tivozanib

Treatment Support Kit: Cabozantinib

PQI: Selpercatinib (Retevmo®) Management

PQI: Selpercatinib (Retevmo®) Genomic Testing Management

Treatment Support Kit: Cabozantinib

Treatment Support Kit: Cabozantinib

Treatment Support Kit: Cabozantinib

PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol

PQI: Encorafenib (Braftovi®) and Binimetinib (Mektovi®) for the Management of NSCLC

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

PQI: Bone Health and the Cancer Patient